Qualigenix provides wound care billing services for wound clinics, hospital-based wound centers, hyperbaric medicine programs, and podiatry practices. Our certified coders bill debridement by tissue depth and surface area, match skin substitute units to the documented wound size, and track authorizations for CTPs, HBOT, and NPWT before treatment starts.
Wound care billing requires codes that match the documented wound: tissue depth for debridement, square centimeters for skin substitutes and NPWT, and session time for hyperbaric oxygen therapy. Each claim also needs measurements, diagnoses, and treatment history that meet Medicare and commercial payer coverage rules. Qualigenix codes wound care claims at 98.9% coding accuracy and overturns 79% of the denials it works. Start with a free wound care billing audit.
Debridement is coded by the deepest tissue removed, not by how long the procedure took. Selective debridement (97597, 97598) and surgical debridement of subcutaneous tissue, muscle, or bone (11042 to 11047) pay very differently. Each is also billed by surface area in 20 sq cm increments. When the note says "debrided to healthy tissue" without naming the tissue level, the coder has to pick the lower code or risk a denial.
Skin substitutes, hyperbaric oxygen therapy, and negative pressure wound therapy are the services commercial payers and Medicare Advantage plans most often require prior authorization for. A clinic that starts a 30-session HBOT series or a weekly CTP application course without an approved authorization can lose payment for the whole series.
Skin substitute claims carry two parts: the application code (15271 to 15278) and the product's HCPCS Q-code, billed in square centimeters. Starting January 1, 2026, Medicare pays non-BLA skin substitutes as incident-to supplies at about $127.28 per sq cm under the Physician Fee Schedule. It no longer pays for discarded product on those items, so JW and JZ modifiers are no longer used for them. Units billed must match what was applied to the wound.
The same wound visit bills differently in a physician office (POS 11), a hospital outpatient department (POS 22), or a nursing facility (POS 31 or 32). In the hospital outpatient setting, HBOT is billed per 30-minute interval with G0277 on the facility claim, while the supervising physician bills 99183. A claim sent with the wrong place of service or on the wrong claim form is rejected or underpaid.
Chronic wound patients come back. A diabetic foot ulcer that heals and reopens, or a venous ulcer treated across two plan years, can hit visit limits, new deductibles, or a change in plan. Eligibility checked once at intake won't catch these changes.
Payers decide medical necessity from the wound record: length, width, and depth at each visit, tissue type, drainage, the underlying condition, and a documented course of standard care before advanced therapy. Missing measurements are one of the most common reasons wound care claims are denied, and the gap is often only found on audit.
Wound care denials cluster around a few causes: modifier 25 on an E/M billed the same day as debridement without a separately documented problem, missing or inconsistent wound measurements, diagnoses that don't support the procedure (for example, a debridement billed without the ulcer's depth coded in ICD-10), and products billed without authorization.
Medicare HBOT coverage follows National Coverage Determination 20.29, which limits coverage to listed conditions. For diabetic foot wounds, that means Wagner grade III or higher after a failed 30-day course of standard wound therapy. Skin substitute coverage changed twice in 2026: the CMS MACs withdrew the skin substitute LCDs that were scheduled for January 1, 2026, and the new Physician Fee Schedule payment rules took effect the same day. Your billing team has to follow both.
Qualigenix assigns your practice a wound care billing team that reviews the clinical note before the claim is built, so the code, units, modifiers, and authorization all match the record.
Our coders read the procedure note for the deepest tissue level removed and the total area treated, then code the base and add-on units to match. When the note doesn't state depth or area, we send a query to the provider before billing instead of downcoding. Qualigenix holds a 98.9% coding accuracy rate and a 98.5% charge capture accuracy rate.
We request and track authorizations for CTPs, HBOT, NPWT, and other advanced therapies by payer, by number of applications or sessions approved, and by expiration date. Your team is alerted before an authorization runs out mid-series.
For every CTP application, we compare the wound size in the note, the product size used, and the units on the claim. Under the 2026 Medicare rules, we bill only applied units for non-BLA products and drop JW and JZ modifiers for Medicare patients.
We bill each encounter for the setting it happened in: professional claims for office-based wound care, facility and professional claims for hospital outpatient wound centers and HBOT, and the correct place-of-service codes for nursing facility and home visits.
Before a new wound episode or treatment series begins, we verify active coverage, deductible status, visit limits, and authorization requirements for the specific services planned.
Our coders check each claim for the measurements, tissue type, diagnosis specificity, and standard-care history the payer needs. Gaps go back to the provider before the claim is sent, not after the denial comes back.
We work wound care denials by root cause, appeal with the clinical record attached, and report the patterns back to your team so they don't repeat. Qualigenix overturns 79% of the denials it works, with an average appeal turnaround of under 9 days.
We track Medicare NCD and MAC policy changes, Medicare Advantage authorization rules, and commercial payer wound care policies, and we update your billing rules when they change. Qualigenix holds a 98.6% compliance and audit pass rate.
A 3-provider podiatry group with roughly 60% Medicare payer mix carried $412,000 in A/R, 38% of it past 120 days. Routine foot care claims (11720, 11721, 11055–11057) had stalled on inconsistent Q7/Q8/Q9 modifiers and class-finding documentation, so payers held or partially paid and nobody worked the remainder. Medicare crossover to secondaries was not being posted, and small patient balances were written off.
We ran a full A/R aging segmentation, worked claims by payer and denial reason rather than by date, rebilled the stalled routine-care claims with corrected modifiers, and reactivated secondary and crossover billing.
A solo podiatrist coding 320 encounters a month was stuck at 82% first-pass acceptance. Routine foot care went out without the systemic-condition diagnosis pairing and class findings Medicare requires, so it read as non-covered. Wound debridement was coded to the wrong depth (11042 for skin and subcutaneous where the note supported 11043 for muscle and fascia). Same-day E/M with a procedure went out without modifier 25 and got bundled.
We rebuilt the coding workflow: diagnosis-to-CPT pairing rules for at-risk foot care, correct Q-modifier logic, depth-based debridement coding tied to the operative note, and disciplined use of modifiers 25 and 59/XS.
A 2-location podiatry practice sat at a 19% denial rate, mostly Medicare routine-foot-care and nail-debridement rejections. The denials clustered in three buckets: medical-necessity rejections on routine foot care (missing qualifying diagnosis and class findings), frequency-edit denials on nail debridement billed inside the 60-day window, and missing Q modifiers that flagged services as non-covered.
We built a front-end denial-prevention layer, checking eligibility and coverage against payer LCDs before claims went out, plus a structured appeal workflow with documentation templates mapped to each denial reason.
Qualigenix coders bill each wound care service line with the CPT, HCPCS, and ICD-10 codes the documentation supports.
Selective debridement of open wounds is billed with 97597 for the first 20 sq cm and 97598 for each additional 20 sq cm. Non-selective debridement, such as enzymatic or wet-to-moist dressings, is billed with 97602.
Qualigenix is system-agnostic: our coders work in the EHR and practice management system your wound care team already uses, whether that's a wound-specific documentation platform or a hospital enterprise system. Across our client base we work in 133 EMR/EHR platforms, so your providers don't change how they chart and your claims go out from your own system.

Qualigenix keeps wound care billing compliant by matching every code to the wound record. Debridement is billed at the tissue depth documented, skin substitute units are matched to the wound size, and HBOT is billed only for conditions Medicare's HBOT coverage rule (NCD 20.29) covers. Before a claim goes out, we check the measurements, diagnoses and standard-care history that payers review on audit. We also follow the 2026 Medicare skin substitute rules, so only applied product is billed and no wastage is claimed on non-BLA products. The result is a 98.6% compliance and audit pass rate, with over- and undercoding held under 2%. All work is HIPAA compliant, and patient data is handled under strict security controls.
Still weighing it? A quick call answers the cost and denial questions for your practice.
Qualigenix quotes wound care billing after reviewing your claim volume, payer mix, and service lines, such as debridement, skin substitutes, and HBOT. The fastest way to get a quote is a free wound care billing audit at 786-259-0231.
Our coders code debridement to the deepest tissue level documented in the procedure note (subcutaneous tissue, muscle or fascia, or bone) and bill add-on units for each additional 20 sq cm treated. If depth or area is missing, we query the provider before the claim goes out.
Yes. Qualigenix bills wound care given in nursing facilities and patients' homes with the correct place-of-service codes and payer rules for each setting.
Yes. Qualigenix takes over existing accounts receivable, works aged wound care claims by payer and denial reason, and has reduced days in A/R from 54 to 36 for client practices. Most practices start with a free AR review.
Yes. Qualigenix requests and tracks prior authorizations for skin substitutes, hyperbaric oxygen therapy, and NPWT, including the number of applications or sessions approved and the expiration date, so a treatment series doesn't run past its approval.
Starting January 1, 2026, Medicare pays non-BLA skin substitutes as incident-to supplies at about $127.28 per sq cm and no longer pays for discarded product, so only applied units are billed and JW and JZ modifiers are dropped for those products. Qualigenix updates your CTP billing to these rules and reconciles units to wound size on every claim.
Yes. Qualigenix is system-agnostic and works in 133 EMR/EHR platforms, so our team bills from the system your wound care providers already use.
Average onboarding at Qualigenix takes 6 days, including system access, payer setup, and a review of your open authorizations and outstanding wound care claims.